Frances Rachel Frankenburg, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Borderline Personality Disorder | 99 | 2024 | 768 | 6.800 |
Why?
|
Personality Disorders | 34 | 2024 | 722 | 2.060 |
Why?
|
Clozapine | 20 | 2019 | 504 | 1.780 |
Why?
|
Antipsychotic Agents | 13 | 2022 | 3067 | 1.150 |
Why?
|
Thiamine Deficiency | 2 | 2008 | 48 | 0.600 |
Why?
|
Self Concept | 4 | 2018 | 1045 | 0.510 |
Why?
|
Schizophrenia | 13 | 2022 | 6937 | 0.510 |
Why?
|
Psychiatric Status Rating Scales | 41 | 2020 | 6019 | 0.500 |
Why?
|
Defense Mechanisms | 3 | 2013 | 180 | 0.490 |
Why?
|
Follow-Up Studies | 54 | 2024 | 39106 | 0.400 |
Why?
|
Psychotic Disorders | 14 | 2019 | 3223 | 0.380 |
Why?
|
Self Mutilation | 6 | 2013 | 57 | 0.370 |
Why?
|
Interpersonal Relations | 11 | 2019 | 1436 | 0.340 |
Why?
|
Comorbidity | 30 | 2024 | 10508 | 0.330 |
Why?
|
Health Status | 5 | 2013 | 4077 | 0.320 |
Why?
|
Korsakoff Syndrome | 1 | 2008 | 18 | 0.310 |
Why?
|
Phenothiazines | 1 | 2008 | 61 | 0.300 |
Why?
|
Chlorpromazine | 1 | 2008 | 111 | 0.300 |
Why?
|
Neurosyphilis | 1 | 2008 | 27 | 0.300 |
Why?
|
One-Carbon Group Transferases | 1 | 2007 | 6 | 0.300 |
Why?
|
Psychotherapy | 6 | 2023 | 1647 | 0.290 |
Why?
|
Self-Assessment | 2 | 2009 | 396 | 0.280 |
Why?
|
Prescription Drugs | 1 | 2014 | 631 | 0.270 |
Why?
|
Neutrophils | 1 | 2019 | 3767 | 0.270 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2164 | 0.270 |
Why?
|
Depressive Disorder | 16 | 2009 | 3728 | 0.270 |
Why?
|
Human Development | 1 | 2007 | 123 | 0.270 |
Why?
|
Malaria, Cerebral | 1 | 2008 | 136 | 0.270 |
Why?
|
Adult | 116 | 2024 | 221177 | 0.270 |
Why?
|
Child Abuse | 9 | 2019 | 1077 | 0.270 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 16 | 2013 | 1988 | 0.260 |
Why?
|
Alcoholism | 3 | 2023 | 1973 | 0.260 |
Why?
|
Temperament | 3 | 2024 | 297 | 0.250 |
Why?
|
Affective Symptoms | 2 | 2007 | 417 | 0.250 |
Why?
|
Lead Poisoning | 1 | 2008 | 322 | 0.240 |
Why?
|
Folic Acid | 2 | 2009 | 1323 | 0.240 |
Why?
|
Somatoform Disorders | 2 | 2007 | 423 | 0.240 |
Why?
|
Depressive Disorder, Major | 5 | 2023 | 4761 | 0.240 |
Why?
|
Suicide | 6 | 2019 | 1601 | 0.240 |
Why?
|
Women's Health | 2 | 2011 | 2065 | 0.230 |
Why?
|
Hyperthermia, Induced | 1 | 2008 | 417 | 0.230 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2005 | 297 | 0.230 |
Why?
|
Social Adjustment | 4 | 2012 | 632 | 0.220 |
Why?
|
Humans | 153 | 2024 | 761504 | 0.220 |
Why?
|
Bupropion | 1 | 2005 | 304 | 0.220 |
Why?
|
Aggression | 6 | 2017 | 750 | 0.220 |
Why?
|
Bipolar Disorder | 9 | 2008 | 5092 | 0.220 |
Why?
|
Remission Induction | 9 | 2024 | 2396 | 0.210 |
Why?
|
Analgesics, Opioid | 2 | 2021 | 3808 | 0.210 |
Why?
|
Female | 116 | 2024 | 392644 | 0.210 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2005 | 489 | 0.200 |
Why?
|
Depersonalization | 2 | 2020 | 39 | 0.190 |
Why?
|
Suicide, Attempted | 5 | 2019 | 1402 | 0.190 |
Why?
|
Severity of Illness Index | 12 | 2020 | 15842 | 0.190 |
Why?
|
Longitudinal Studies | 22 | 2023 | 14605 | 0.190 |
Why?
|
Valproic Acid | 3 | 2002 | 443 | 0.190 |
Why?
|
Pirenzepine | 1 | 2001 | 116 | 0.190 |
Why?
|
Male | 101 | 2024 | 360804 | 0.190 |
Why?
|
Personality | 3 | 2019 | 554 | 0.190 |
Why?
|
Antimalarials | 1 | 2008 | 907 | 0.180 |
Why?
|
Psychotropic Drugs | 4 | 2015 | 888 | 0.180 |
Why?
|
Prospective Studies | 33 | 2024 | 54425 | 0.180 |
Why?
|
England | 1 | 2021 | 526 | 0.180 |
Why?
|
Sexual Partners | 2 | 2016 | 796 | 0.170 |
Why?
|
Time Factors | 15 | 2019 | 39967 | 0.170 |
Why?
|
Gastric Bypass | 1 | 2008 | 818 | 0.170 |
Why?
|
Leukocyte Count | 3 | 2019 | 1596 | 0.170 |
Why?
|
Cognition Disorders | 5 | 2017 | 3979 | 0.170 |
Why?
|
Recurrence | 15 | 2024 | 8465 | 0.170 |
Why?
|
Tobacco Use Disorder | 1 | 2005 | 703 | 0.170 |
Why?
|
Health Services | 1 | 2004 | 752 | 0.170 |
Why?
|
Interview, Psychological | 8 | 2016 | 809 | 0.160 |
Why?
|
Neuroleptic Malignant Syndrome | 3 | 1995 | 74 | 0.160 |
Why?
|
Young Adult | 31 | 2024 | 59243 | 0.160 |
Why?
|
Eicosapentaenoic Acid | 1 | 2003 | 561 | 0.160 |
Why?
|
Identity Crisis | 2 | 2009 | 12 | 0.160 |
Why?
|
Prevalence | 16 | 2024 | 15732 | 0.160 |
Why?
|
Bulimia | 4 | 1990 | 400 | 0.160 |
Why?
|
Child Abuse, Sexual | 9 | 2010 | 403 | 0.150 |
Why?
|
Personality Assessment | 4 | 2019 | 650 | 0.150 |
Why?
|
Delayed-Action Preparations | 1 | 2022 | 962 | 0.150 |
Why?
|
Personality Development | 3 | 2005 | 244 | 0.150 |
Why?
|
Chronic Disease | 5 | 2013 | 9318 | 0.150 |
Why?
|
Patient Compliance | 2 | 2008 | 2690 | 0.150 |
Why?
|
Patient Education as Topic | 1 | 2008 | 2319 | 0.150 |
Why?
|
Edema | 1 | 2022 | 766 | 0.150 |
Why?
|
Adolescent | 48 | 2020 | 88319 | 0.150 |
Why?
|
Lithium | 4 | 1991 | 596 | 0.150 |
Why?
|
Dissociative Disorders | 3 | 2008 | 234 | 0.140 |
Why?
|
Mental Competency | 1 | 2018 | 176 | 0.140 |
Why?
|
Self Report | 3 | 2024 | 3724 | 0.140 |
Why?
|
Violence | 4 | 2012 | 936 | 0.140 |
Why?
|
Back Pain | 2 | 2014 | 545 | 0.140 |
Why?
|
Obesity | 2 | 2011 | 12947 | 0.130 |
Why?
|
Mental Disorders | 7 | 2012 | 6845 | 0.130 |
Why?
|
Stress Disorders, Post-Traumatic | 5 | 2012 | 4575 | 0.130 |
Why?
|
1-Naphthylamine | 2 | 1996 | 49 | 0.130 |
Why?
|
History, 20th Century | 5 | 2017 | 2767 | 0.130 |
Why?
|
Self-Injurious Behavior | 3 | 2013 | 566 | 0.120 |
Why?
|
Agranulocytosis | 1 | 1994 | 97 | 0.120 |
Why?
|
Hospitalization | 20 | 2019 | 10723 | 0.120 |
Why?
|
Mental Status Schedule | 1 | 2015 | 314 | 0.120 |
Why?
|
Crime Victims | 2 | 2012 | 347 | 0.120 |
Why?
|
Urination Disorders | 1 | 1996 | 238 | 0.120 |
Why?
|
Leukopenia | 1 | 1995 | 213 | 0.120 |
Why?
|
Anticonvulsants | 2 | 2002 | 1906 | 0.110 |
Why?
|
Smoking Cessation | 1 | 2005 | 2056 | 0.110 |
Why?
|
Shame | 1 | 2014 | 80 | 0.110 |
Why?
|
Choice Behavior | 2 | 2013 | 824 | 0.110 |
Why?
|
Respiration Disorders | 1 | 1996 | 367 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2003 | 1390 | 0.110 |
Why?
|
Social Behavior | 3 | 2011 | 1135 | 0.110 |
Why?
|
Osteoarthritis | 2 | 2014 | 1063 | 0.100 |
Why?
|
Interviews as Topic | 5 | 2014 | 2696 | 0.100 |
Why?
|
Marriage | 1 | 2014 | 351 | 0.100 |
Why?
|
Delirium | 1 | 2004 | 1668 | 0.100 |
Why?
|
Commitment of Mentally Ill | 2 | 1982 | 94 | 0.100 |
Why?
|
Personality Inventory | 5 | 2006 | 1019 | 0.100 |
Why?
|
Rehabilitation, Vocational | 2 | 2010 | 81 | 0.100 |
Why?
|
Tinnitus | 1 | 1994 | 196 | 0.100 |
Why?
|
Schizophrenic Psychology | 3 | 1994 | 1647 | 0.100 |
Why?
|
Spouses | 1 | 2014 | 283 | 0.100 |
Why?
|
Tourette Syndrome | 1 | 1994 | 395 | 0.100 |
Why?
|
Eosinophilia | 2 | 1995 | 560 | 0.100 |
Why?
|
Cognitive Dissonance | 1 | 2010 | 14 | 0.090 |
Why?
|
Impulsive Behavior | 4 | 2007 | 346 | 0.090 |
Why?
|
Intensive Care Units | 1 | 2004 | 3745 | 0.090 |
Why?
|
Rape | 4 | 2005 | 131 | 0.090 |
Why?
|
Body Weight | 4 | 1998 | 4618 | 0.090 |
Why?
|
Trifluoperazine | 1 | 1990 | 37 | 0.090 |
Why?
|
Anxiety Disorders | 6 | 2012 | 2720 | 0.090 |
Why?
|
Anorexia Nervosa | 3 | 2010 | 1361 | 0.080 |
Why?
|
Drug Administration Schedule | 6 | 2014 | 4853 | 0.080 |
Why?
|
Projection | 1 | 2009 | 18 | 0.080 |
Why?
|
Capgras Syndrome | 1 | 1989 | 9 | 0.080 |
Why?
|
Fibromyalgia | 1 | 2014 | 405 | 0.080 |
Why?
|
Income | 2 | 2016 | 1877 | 0.080 |
Why?
|
Electroconvulsive Therapy | 1 | 2014 | 500 | 0.080 |
Why?
|
Family Characteristics | 1 | 2014 | 1004 | 0.080 |
Why?
|
Social Security | 1 | 2009 | 101 | 0.080 |
Why?
|
Diazepam | 1 | 1990 | 215 | 0.080 |
Why?
|
Porphyrias | 1 | 2008 | 57 | 0.080 |
Why?
|
Bread | 1 | 2008 | 23 | 0.080 |
Why?
|
Middle Aged | 34 | 2024 | 220895 | 0.080 |
Why?
|
Substance-Related Disorders | 10 | 2017 | 4420 | 0.080 |
Why?
|
S-Adenosylmethionine | 2 | 2007 | 218 | 0.080 |
Why?
|
Agnosia | 1 | 1989 | 66 | 0.080 |
Why?
|
Treatment Outcome | 11 | 2018 | 64680 | 0.080 |
Why?
|
Drug Therapy, Combination | 8 | 2004 | 6310 | 0.080 |
Why?
|
Gasoline | 1 | 2008 | 53 | 0.080 |
Why?
|
Massachusetts | 10 | 2014 | 8830 | 0.080 |
Why?
|
Bulimia Nervosa | 1 | 2010 | 206 | 0.080 |
Why?
|
Irritable Bowel Syndrome | 1 | 2013 | 455 | 0.070 |
Why?
|
Life Style | 2 | 2013 | 3917 | 0.070 |
Why?
|
Parent-Child Relations | 2 | 2000 | 761 | 0.070 |
Why?
|
Circadian Rhythm | 1 | 2019 | 2576 | 0.070 |
Why?
|
Prognosis | 11 | 2019 | 29625 | 0.070 |
Why?
|
History, 19th Century | 2 | 2008 | 720 | 0.070 |
Why?
|
Fluoxetine | 3 | 2004 | 733 | 0.070 |
Why?
|
Carbamazepine | 1 | 1988 | 224 | 0.070 |
Why?
|
History, 21st Century | 2 | 2017 | 1567 | 0.070 |
Why?
|
Thiamine | 1 | 2008 | 160 | 0.070 |
Why?
|
Food, Fortified | 1 | 2008 | 190 | 0.070 |
Why?
|
Benzodiazepines | 2 | 2004 | 1132 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2008 | 15631 | 0.070 |
Why?
|
Sex Offenses | 1 | 2010 | 352 | 0.070 |
Why?
|
Life Change Events | 3 | 2012 | 952 | 0.070 |
Why?
|
Reproducibility of Results | 9 | 2015 | 20098 | 0.070 |
Why?
|
Neuropsychological Tests | 2 | 2017 | 7045 | 0.070 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2007 | 276 | 0.070 |
Why?
|
Double-Blind Method | 4 | 2003 | 12341 | 0.060 |
Why?
|
Europe | 2 | 2008 | 3422 | 0.060 |
Why?
|
Paranoid Disorders | 3 | 2013 | 61 | 0.060 |
Why?
|
Mental Health Services | 2 | 2010 | 1730 | 0.060 |
Why?
|
Sex Factors | 8 | 2010 | 10552 | 0.060 |
Why?
|
Antisocial Personality Disorder | 4 | 2012 | 224 | 0.060 |
Why?
|
Muscle Weakness | 1 | 2008 | 412 | 0.060 |
Why?
|
Pilot Projects | 4 | 2003 | 8631 | 0.060 |
Why?
|
Pancreatitis | 1 | 1992 | 1096 | 0.060 |
Why?
|
Fever | 2 | 1995 | 1618 | 0.060 |
Why?
|
Pain | 2 | 2023 | 5073 | 0.060 |
Why?
|
Australia | 1 | 2008 | 1250 | 0.060 |
Why?
|
Case-Control Studies | 6 | 2017 | 22176 | 0.060 |
Why?
|
Vitamin B 12 | 1 | 2007 | 524 | 0.060 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2013 | 1081 | 0.060 |
Why?
|
Anxiety | 3 | 2014 | 4573 | 0.060 |
Why?
|
Homocysteine | 1 | 2007 | 638 | 0.060 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 2629 | 0.060 |
Why?
|
Obsessive Behavior | 1 | 1984 | 51 | 0.060 |
Why?
|
Child | 15 | 2019 | 80153 | 0.050 |
Why?
|
Risk Factors | 15 | 2019 | 74206 | 0.050 |
Why?
|
Family | 3 | 2009 | 3194 | 0.050 |
Why?
|
Family Therapy | 1 | 1985 | 215 | 0.050 |
Why?
|
Clothing | 1 | 1984 | 97 | 0.050 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2005 | 412 | 0.050 |
Why?
|
Gallstones | 1 | 2006 | 284 | 0.050 |
Why?
|
Compulsive Behavior | 1 | 1984 | 117 | 0.050 |
Why?
|
Drug Interactions | 2 | 2005 | 1416 | 0.050 |
Why?
|
Haloperidol | 1 | 2004 | 389 | 0.050 |
Why?
|
Ambulatory Care | 5 | 1996 | 2775 | 0.050 |
Why?
|
Dementia | 1 | 2017 | 2686 | 0.050 |
Why?
|
Attitude to Health | 1 | 2011 | 2025 | 0.050 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2006 | 303 | 0.050 |
Why?
|
Mentally Ill Persons | 1 | 1982 | 128 | 0.050 |
Why?
|
Abdominal Pain | 1 | 2008 | 1071 | 0.050 |
Why?
|
Age Factors | 7 | 2014 | 18395 | 0.050 |
Why?
|
Huntington Disease | 1 | 1989 | 1144 | 0.050 |
Why?
|
Hypnotics and Sedatives | 1 | 2009 | 1179 | 0.050 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2003 | 189 | 0.050 |
Why?
|
Urinary Incontinence | 1 | 2006 | 489 | 0.050 |
Why?
|
Sexuality | 1 | 2003 | 180 | 0.050 |
Why?
|
Psychological Tests | 1 | 2003 | 640 | 0.050 |
Why?
|
Hostility | 1 | 2002 | 183 | 0.050 |
Why?
|
Seizures | 1 | 1994 | 2957 | 0.050 |
Why?
|
Child Behavior Disorders | 1 | 2006 | 804 | 0.050 |
Why?
|
Intelligence | 2 | 2018 | 924 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2015 | 1572 | 0.050 |
Why?
|
Deafness | 1 | 1985 | 459 | 0.050 |
Why?
|
Parents | 1 | 2014 | 3563 | 0.040 |
Why?
|
Cross-Sectional Studies | 6 | 2013 | 26125 | 0.040 |
Why?
|
Certification | 1 | 1983 | 418 | 0.040 |
Why?
|
Personality Tests | 2 | 1990 | 81 | 0.040 |
Why?
|
Anger | 1 | 2002 | 406 | 0.040 |
Why?
|
Disabled Persons | 1 | 2009 | 1225 | 0.040 |
Why?
|
Cognition | 3 | 2013 | 6990 | 0.040 |
Why?
|
Employment | 2 | 2018 | 1118 | 0.040 |
Why?
|
Preventive Psychiatry | 1 | 2019 | 6 | 0.040 |
Why?
|
Emotions | 2 | 2023 | 2739 | 0.040 |
Why?
|
Boredom | 1 | 1998 | 6 | 0.040 |
Why?
|
Psychometrics | 7 | 2015 | 3065 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 1994 | 3708 | 0.040 |
Why?
|
Negativism | 1 | 2018 | 23 | 0.040 |
Why?
|
Remission, Spontaneous | 2 | 2010 | 384 | 0.040 |
Why?
|
Observer Variation | 2 | 2002 | 2606 | 0.040 |
Why?
|
Gastroesophageal Reflux | 1 | 2006 | 819 | 0.040 |
Why?
|
Guilt | 1 | 1998 | 96 | 0.040 |
Why?
|
Body Mass Index | 3 | 2013 | 12953 | 0.040 |
Why?
|
Psychiatric Department, Hospital | 2 | 2010 | 126 | 0.040 |
Why?
|
Placebos | 1 | 2002 | 1667 | 0.040 |
Why?
|
Mental Health | 1 | 2012 | 3250 | 0.040 |
Why?
|
United States | 6 | 2019 | 72334 | 0.040 |
Why?
|
Adolescent Behavior | 1 | 2006 | 1190 | 0.040 |
Why?
|
Salivation | 1 | 1996 | 22 | 0.040 |
Why?
|
Individuality | 1 | 2019 | 301 | 0.040 |
Why?
|
Inpatients | 2 | 2006 | 2548 | 0.030 |
Why?
|
Sertraline | 2 | 1996 | 209 | 0.030 |
Why?
|
Fracture Fixation, Intramedullary | 1 | 1978 | 159 | 0.030 |
Why?
|
Enuresis | 1 | 1996 | 50 | 0.030 |
Why?
|
Mandelic Acids | 1 | 1996 | 46 | 0.030 |
Why?
|
Parasympatholytics | 1 | 1996 | 89 | 0.030 |
Why?
|
Deamino Arginine Vasopressin | 1 | 1996 | 87 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2008 | 4028 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5336 | 0.030 |
Why?
|
Bradycardia | 1 | 1996 | 299 | 0.030 |
Why?
|
Health Care Costs | 2 | 2004 | 3242 | 0.030 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 1994 | 165 | 0.030 |
Why?
|
Anthropometry | 1 | 1998 | 1349 | 0.030 |
Why?
|
Economics, Pharmaceutical | 1 | 1993 | 87 | 0.030 |
Why?
|
Health Behavior | 1 | 2004 | 2643 | 0.030 |
Why?
|
Emergency Medical Services | 1 | 2004 | 1923 | 0.030 |
Why?
|
Disease Progression | 4 | 2012 | 13506 | 0.030 |
Why?
|
Paranoid Personality Disorder | 1 | 2012 | 7 | 0.030 |
Why?
|
Passive-Aggressive Personality Disorder | 1 | 2012 | 5 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2008 | 4486 | 0.030 |
Why?
|
Dependent Personality Disorder | 1 | 2012 | 13 | 0.030 |
Why?
|
Patient Admission | 2 | 2016 | 1367 | 0.030 |
Why?
|
Research Design | 1 | 2008 | 6180 | 0.030 |
Why?
|
Probability | 1 | 1997 | 2477 | 0.020 |
Why?
|
Ontario | 2 | 1982 | 398 | 0.020 |
Why?
|
Psychiatry | 1 | 1983 | 1693 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 6484 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 1996 | 15500 | 0.020 |
Why?
|
Cerebral Ventriculography | 1 | 1990 | 44 | 0.020 |
Why?
|
Aged | 8 | 2014 | 169289 | 0.020 |
Why?
|
Hip Fractures | 1 | 1978 | 988 | 0.020 |
Why?
|
Quality of Life | 1 | 2011 | 13367 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 1993 | 983 | 0.020 |
Why?
|
Proportional Hazards Models | 3 | 2012 | 12463 | 0.020 |
Why?
|
Regression Analysis | 3 | 2004 | 6343 | 0.020 |
Why?
|
Sick Role | 1 | 1989 | 229 | 0.020 |
Why?
|
Manuals as Topic | 1 | 1987 | 99 | 0.020 |
Why?
|
India | 1 | 1994 | 2348 | 0.020 |
Why?
|
Delusions | 1 | 1990 | 298 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 17904 | 0.020 |
Why?
|
Sex Characteristics | 1 | 1998 | 2639 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2901 | 0.020 |
Why?
|
Self Disclosure | 1 | 2008 | 249 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2006 | 5840 | 0.020 |
Why?
|
Diethylstilbestrol | 1 | 1987 | 87 | 0.020 |
Why?
|
Hallucinations | 1 | 1990 | 366 | 0.020 |
Why?
|
Drug Industry | 1 | 1993 | 788 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1994 | 10766 | 0.020 |
Why?
|
Asthma | 1 | 2006 | 6234 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 9053 | 0.020 |
Why?
|
Colitis | 1 | 1995 | 1233 | 0.020 |
Why?
|
Psychoses, Substance-Induced | 1 | 1987 | 99 | 0.020 |
Why?
|
Neurotic Disorders | 1 | 2006 | 77 | 0.020 |
Why?
|
Canada | 2 | 1983 | 2122 | 0.020 |
Why?
|
Hypertension | 1 | 2006 | 8540 | 0.020 |
Why?
|
Age of Onset | 2 | 2006 | 3305 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2006 | 303 | 0.020 |
Why?
|
Long-Term Care | 1 | 2010 | 633 | 0.020 |
Why?
|
Neurologic Examination | 1 | 1989 | 916 | 0.020 |
Why?
|
Individuation | 1 | 1985 | 23 | 0.020 |
Why?
|
Sign Language | 1 | 1985 | 12 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2013 | 1835 | 0.020 |
Why?
|
Stimulation, Chemical | 2 | 1996 | 306 | 0.020 |
Why?
|
Schizoid Personality Disorder | 1 | 2004 | 14 | 0.020 |
Why?
|
Survival Analysis | 2 | 2009 | 10090 | 0.020 |
Why?
|
Sleep | 2 | 2013 | 4768 | 0.020 |
Why?
|
Sleep Stages | 1 | 1989 | 694 | 0.020 |
Why?
|
Socialization | 1 | 2005 | 87 | 0.020 |
Why?
|
Family Health | 1 | 2009 | 1257 | 0.010 |
Why?
|
Adolescent Psychiatry | 1 | 2006 | 157 | 0.010 |
Why?
|
Social Conformity | 1 | 1984 | 39 | 0.010 |
Why?
|
Attention | 1 | 1994 | 2396 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2927 | 0.010 |
Why?
|
Social Environment | 1 | 1989 | 1020 | 0.010 |
Why?
|
Cultural Characteristics | 1 | 1985 | 251 | 0.010 |
Why?
|
Hyperphagia | 1 | 1984 | 139 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5871 | 0.010 |
Why?
|
Electroencephalography | 2 | 1989 | 6225 | 0.010 |
Why?
|
History, 17th Century | 1 | 1982 | 108 | 0.010 |
Why?
|
Sleep Apnea Syndromes | 1 | 1991 | 975 | 0.010 |
Why?
|
Recovery of Function | 1 | 2013 | 2979 | 0.010 |
Why?
|
History, 18th Century | 1 | 1982 | 207 | 0.010 |
Why?
|
Logistic Models | 2 | 2009 | 13255 | 0.010 |
Why?
|
Mass Screening | 1 | 2017 | 5428 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1997 | 4481 | 0.010 |
Why?
|
Syndrome | 1 | 2007 | 3267 | 0.010 |
Why?
|
Drug Therapy | 1 | 2004 | 503 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 1993 | 5492 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21353 | 0.010 |
Why?
|
Parkinson Disease | 1 | 1994 | 2877 | 0.010 |
Why?
|
Psychopathology | 1 | 2003 | 432 | 0.010 |
Why?
|
Social Support | 1 | 2009 | 2171 | 0.010 |
Why?
|
Body Image | 1 | 1984 | 638 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2013 | 20570 | 0.010 |
Why?
|
Polypharmacy | 1 | 2001 | 306 | 0.010 |
Why?
|
Professional-Patient Relations | 1 | 1983 | 726 | 0.010 |
Why?
|
Drug Combinations | 1 | 2004 | 2048 | 0.010 |
Why?
|
Spouse Abuse | 1 | 1999 | 182 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 9646 | 0.010 |
Why?
|
Domestic Violence | 1 | 1999 | 182 | 0.010 |
Why?
|
Psychotherapy, Group | 1 | 2001 | 412 | 0.010 |
Why?
|
Sialorrhea | 1 | 1996 | 25 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 1991 | 8002 | 0.010 |
Why?
|
Joint Prosthesis | 1 | 1978 | 253 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15266 | 0.010 |
Why?
|
Mood Disorders | 1 | 2003 | 1127 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2003 | 14666 | 0.010 |
Why?
|
Outpatients | 1 | 2004 | 1597 | 0.010 |
Why?
|
Models, Psychological | 1 | 2000 | 828 | 0.010 |
Why?
|
Paroxetine | 1 | 1996 | 182 | 0.010 |
Why?
|
Affective Disorders, Psychotic | 1 | 1996 | 186 | 0.010 |
Why?
|
Sleep, REM | 2 | 1989 | 595 | 0.010 |
Why?
|
Retrospective Studies | 5 | 2002 | 80636 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1987 | 2518 | 0.010 |
Why?
|
Cause of Death | 1 | 2005 | 3683 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1993 | 201 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8529 | 0.010 |
Why?
|
Diagnosis, Differential | 3 | 1995 | 12974 | 0.010 |
Why?
|
Perphenazine | 1 | 1991 | 33 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2005 | 3205 | 0.010 |
Why?
|
Clonazepam | 1 | 1991 | 135 | 0.010 |
Why?
|
Quality Control | 1 | 1993 | 832 | 0.010 |
Why?
|
Respiratory Therapy | 1 | 1991 | 125 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2009 | 58976 | 0.000 |
Why?
|
Lithium Carbonate | 1 | 1989 | 179 | 0.000 |
Why?
|
Dilatation, Pathologic | 1 | 1990 | 527 | 0.000 |
Why?
|
Reference Values | 1 | 1993 | 4920 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 36426 | 0.000 |
Why?
|
Terminology as Topic | 1 | 1991 | 1530 | 0.000 |
Why?
|
Internship and Residency | 1 | 1983 | 5880 | 0.000 |
Why?
|
Reaction Time | 1 | 1989 | 2082 | 0.000 |
Why?
|
Affect | 1 | 1990 | 1486 | 0.000 |
Why?
|
Weight Gain | 1 | 1991 | 2348 | 0.000 |
Why?
|
Child, Preschool | 1 | 2002 | 42230 | 0.000 |
Why?
|
Infant | 1 | 2000 | 36192 | 0.000 |
Why?
|
Pregnancy | 1 | 1987 | 29874 | 0.000 |
Why?
|